Skip to Content

Agenda

Saturday, February 27, 2010

7:00 am

Registration and Breakfast

7:55

Welcome and Announcements
Gary J. Whitman, MD

Session I

Moderator: Gary J. Whitman, MD

8:00

How to Design an Efficient Breast Imaging Practice
Ellen Shaw de Paredes, MD

8:30

Breast Cancer Risk Assessment
Powel H. Brown, MD, PhD

9:00

Screening Mammography Update
Karla Sepúlveda, MD

9:30

Screening for Breast Cancer with Sonography and MRI
Gary J. Whitman, MD

10:00

Break

10:30

Panel Discussion: Screening High Risk Women
Powel H. Brown, MD, PhD; Karla Sepúlveda, MD; Ellen Shaw de Paredes, MD; and Gary J. Whitman, MD

11:00

Update on Asymmetries and Architectural Distortions
Ellen Shaw de Paredes, MD

11:30

Challenging Calcification Cases
Phan T. Huynh, MD

Noon

Break / Pick up Box Lunch

Session II

Moderator: Emily Sedgwick, MD

12:15 pm

Medico Legal Issues in Breast Imaging (Ethics)
Alfred B. Watson, Jr., MD

1:15

Breast Medical Oncology Update
C. Kent Osborne, MD

1:45

Breast Surgery Update
Treneth P. Baker, MD

2:15

Break

2:30

Breast Ultrasound-guided Biopsy Update
Phan T. Huynh, MD

3:00

Breast MRI Interpretation
Robyn L. Birdwell, MD

3:30

Breast MRI-guided Biopsy Update
Emily Sedgwick, MD

4:00

Molecular Imaging
Robyn L. Birdwell, MD

4:30

Panel Discussion: What Modality When?
Robyn L. Birdwell, MD; Phan T. Huynh, MD; Emily Sedgwick, MD; and Ellen Shaw de Paredes, MD

5:00 pm

Adjourn

Sunday, February 28, 2010

7:00 am

Registration and Breakfast

7:55

Program Notes
Gary J. Whitman, MD

Session III

Moderator: Phan T. Huynh, MD

8:00

Digital Mammography Update
Robyn L. Birdwell, MD

8:30

Telemammography
Ellen Shaw de Paredes, MD

9:00

Computer-aided Detection in Mammography
Robyn L. Birdwell, MD

9:30

Stereotactic Biopsy Update
Ellen Shaw de Paredes, MD

10:00

Break

10:30

Imaging of High-Risk Lesions
Emily Sedgwick, MD

11:00

Pathology of High-Risk Lesions
Savitri Krishnamurthy, MD

11:30

Panel Discussion: Evaluation of Patients with Known High-Risk Lesions
Phan T. Huynh, MD; Savitri Krishnamurthy, MD; Emily Sedgwick, MD; and Gary J. Whitman, MD

Noon

Break / Pick up Box Lunch

Session IV

Moderator: Gary J. Whitman, MD

12:15 pm

Case-of-the-Day Revealed
Beatriz Adrada, MD

1:00

Imaging of Ductal Carcinoma in situ
Ward C. Parsons III, MD

1:30

Pathology of Ductal Carcinoma in situ
Savitri Krishnamurthy, MD

2:00

Panel Discussion: Ductal Carcinoma in Situ
Phan T. Huynh, MD; Savitri Krishnamurthy, MD; Ward C. Parsons III, MD; Emily Sedgwick, MD; and Gary J. Whitman, MD

2:30

Break

3:00

Workshops

1.

Mammographic Positioning

 

Marilyn Bynoe
Ronna Cotton, RT(R)(M)
Donna L. Fehl, RT(R)(M)
Danielle J. McDaniel, BS, RT(R)(M)
Maria T. Montemayor, BS, RT(R)(M)(QM)
Julie Higgs Noel, RT(R)(M)
Regina M. Noseworthy, RT(R)(M)
Falguni Patel, BS, RT(R)(M)
Deborah A. Thames, RT(R)(M)

2.

Digital Mammography Quality Control

 

William R. Geiser, MS

3.

Digital Mammography Interpretation at the Workstation

 

Basak Erguvan Dogan, MD
Tamara Haygood, PhD, MD
Lumarie Santiago, MD

4.

Hands-on Breast Ultrasound Biopsy

 

Shelia K. Bratton, RDMS
Selin Carkaci, MD
Phan T. Huynh, MD
Flavia E. Posleman Monetto, MD, RDMS
Karla Sepúlveda, MD
Tanya W. Stephens, MD
Jaclynn Thai-Macias, RT(R)(VS), RDMS

5.

Hands-on Breast MRI-guided Biopsy

 

Huong Le-Petross, MD
Brandy J. Reed, BS, RT(R)(MR)
Krista R. Runge, BS, RT(R)(MR)
Emily Sedgwick, MD
Jason Stafford, PhD

6.

Stereotactic Biopsy

 

Debora J. Dawson, RT(R)(M)
Gary J. Whitman, MD

7.

Breast Gamma Imaging

 

Ward C. Parsons III, MD

8.

How to Give Bad News to Patients

 

Mary W. Rose, PsyD, CSBM

9.

 Interesting Breast Imaging Cases

 

Deanna Lane, MD

10.

Update on Nephrogenic Systemic Fibrosis

 

Benjamin Y. Cheong, MD

3:30

Repeat Workshops 1-10

4:00

Repeat Workshops 1-10

4:30 pm

Conference Adjournment


The University of Texas M. D. Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. M. D. Anderson also requires that all faculty disclose any unlabeled use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your educational experience. M. D. Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth.

Photographing, audiotaping, and videotaping are prohibited.

Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail this material to CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration.


© 2010 The University of Texas M. D. Anderson Cancer Center